Voinosis
PrivateLast Round
Strategic
Jul 7, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Voinosis operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Strategic round in July 2026.
Voinosis is a healthcare technology company that develops AI-powered voice analysis solutions for the early detection and management of cognitive impairment, dementia, and hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Voinosis Comparables
Compare Voinosis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIBLE Therapeutics | 89% | |
| HAII | 81% | |
| Accexible | 81% |
For institutional investors. Book with your work email.
Voinosis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 7, 2026 | ||||
| Early Funding | Jun 4, 2026 | ||||
| Grant | Mar 1, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Voinosis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
Daewoong Pharmaceutical participated in the round.
- Jun 4, 2026
Raised $4M in early funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 12, 2026
At the DETO 2026 technology conference in South Korea in Nov '26, Voinosis Inc. is building an AI system that analyzes pitch, pauses, rhythm and response time to screen for potential cognitive changes.
For institutional investors. Book with your work email.
Voinosis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Voinosis's valuation, stock price, and market status.
Is Voinosis a public or private company?
Voinosis is a private company.
What is the current stock price of Voinosis?
Voinosis is a private company, so its shares have no public market price. Caplight tracks Voinosis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Voinosis worth (valuation)?
Valuation information for Voinosis is not publicly available.
Can I buy Voinosis stock?
Voinosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Voinosis's last funding round?
Voinosis's most recent funding round was Strategic on July 7, 2026.
Who are the main investors in Voinosis?
Key investors in Voinosis include Government of South Korea.
Will Voinosis IPO soon?
No public IPO plans have been announced for Voinosis.
How can I track Voinosis secondary market activity?
Caplight tracks bids, offers, and trades in Voinosis's shares on secondary markets.